PD-L1/TLR7 dual-targeting nanobody-drug conjugate mediates potent tumor regression via elevating tumor immunogenicity in a host-expressed PD-L1 bias-dependent way
PD-L1/TLR7双靶向纳米抗体-药物偶联物通过宿主表达的PD-L1偏向性依赖的方式提高肿瘤免疫原性,从而介导强效的肿瘤消退。
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2022-004590
Yu, Xiaolu; Long, Yiru; Chen, Binfan; Tong, Yongliang; Shan, Mengwen; Jia, Xiaomin; Hu, Chao; Liu, Meng; Zhou, Ji; Tang, Feng; Lu, Henglei; Chen, Runqiu; Xu, Pan; Huang, Wei; Ren, Jin; Wan, Yakun; Sun, Jianhua; Li, Jia; Jin, Guangyi; Gong, Likun